Isabel Nájera

Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility

P. Harrigan, B. Larder, S. Kemp, 1996, Journal of virology.

Review Resistance to Mericitabine, a Nucleoside Analogue Inhibitor of Hcv Rna-dependent Rna Polymerase

J. Pawlotsky, I. Jacobson, I. Nájera, 2022 .

Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group.

C Stone, P. Harrigan, B. Larder, 2000, The Journal of infectious diseases.